|
gptkbp:instanceOf
|
gptkb:chemical_compound
gptkb:benzodiazepine
|
|
gptkbp:abusePotential
|
yes
|
|
gptkbp:CASNumber
|
28910-91-0
|
|
gptkbp:detectionInUrine
|
yes
|
|
gptkbp:drugClass
|
gptkb:sedative
gptkb:benzodiazepine
gptkb:hypnotic
|
|
gptkbp:effect
|
gptkb:anticonvulsant
muscle relaxation
sedation
anxiolysis
|
|
gptkbp:eliminationHalfLife
|
long (estimated 40-250 hours)
|
|
gptkbp:firstReported
|
1970s
|
|
gptkbp:hasMolecularFormula
|
C15H10ClFN2O
|
|
gptkbp:hasSMILES
|
C1=CC=C2C(=C1)C(=O)N(C3=CC=CC=C3F)C(=N2)Cl
|
|
gptkbp:IUPAC_Name
|
7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
|
|
gptkbp:legalStatus
|
unscheduled (varies by country)
|
|
gptkbp:metabolism
|
gptkb:midazolam
gptkb:flurazepam
fludiazepam
flutoprazepam
|
|
gptkbp:molecularWeight
|
288.71 g/mol
|
|
gptkbp:otherName
|
desalkylflurazepam
norflurazepam
|
|
gptkbp:parent
|
gptkb:midazolam
gptkb:flurazepam
fludiazepam
flutoprazepam
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL2106012
68783
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:structureType
|
1,4-benzodiazepine
|
|
gptkbp:target
|
gptkb:GABAA_receptor
|
|
gptkbp:UNII
|
6QK0I6D8HC
|
|
gptkbp:usedAs
|
gptkb:recreational_drug
|
|
gptkbp:bfsParent
|
gptkb:flurazepam
|
|
gptkbp:bfsLayer
|
10
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
N-desalkylflurazepam
|